Viewing StudyNCT05710848



Ignite Creation Date: 2024-05-06 @ 6:35 PM
Last Modification Date: 2024-10-26 @ 2:50 PM
Study NCT ID: NCT05710848
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2022-12-15

Brief Title: A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Sponsor: SURGE Therapeutics
Organization: SURGE Therapeutics

Conditions & Keywords Data

Conditions:
Name
Non-muscle-invasive Bladder Cancer
Keywords:
Name View
BCG View
Open-label View
Dose escalation View
STM-416 View
Resiquimod View
Toll-like receptor 78 View
Non-Muscle Invasive Bladder Cancer View
TURBT View
Immunotherapy View